FY25 Appendix 4E & Annual Report
| Stock | Earlypay Ltd (EPY.ASX) |
|---|---|
| Release Time | 26 Aug 2025, 9:43 a.m. |
| Price Sensitive | Yes |
FY25 Appendix 4E & Annual Report
- Statutory NPAT up 31% to $2.9m, adjusted NPAT up 23.7% to $5.1m
- Margins expanded in Invoice Finance, credit performance improved
- Commenced consolidation of legacy Invoice Finance systems
Earlypay Ltd continued to make financial and operational progress in FY25, building on strategic foundations established in prior years. While total Funds in Use (FIU) remained flat at $249.4m, there were material movements within the product segments. Invoice Finance FIU declined 10% to $118.6m, Trade Finance FIU declined 72% to $6.6m, while Equipment Finance FIU grew 33% to $124.2m. The rebalancing to a more diversified portfolio focused on Invoice Finance and Equipment Finance has seen credit performance improve, with Credit Loss Expense of 0.75% in FY25 compared to 1.58% in FY24. The company reported a 31% increase in statutory net profit after tax to $2.9m, and a 23.7% rise in adjusted NPAT to $5.1m. This was underpinned by strong growth in Equipment Finance, though performance in the Invoice Finance portfolio was disappointing. Minimising client attrition and increasing new originations is the primary focus for FY26, to grow Funds in Use and maximise the operating leverage in the business. The company has commenced the consolidation of its three legacy Invoice Finance loan management systems onto a single, modern platform, a key priority for FY26.
A fully franked dividend of 0.65 cents per ordinary share for the financial year ended 30 June 2025 has been declared subsequent to balance date.
As financial and operational pillars continue to strengthen, the focus in FY26 is squarely on growing the invoice and equipment finance portfolios to drive earnings and earnings per share higher. The company expects to have around $10m (~3.6 cents per share) of surplus capital available for capital management initiatives, which may include resuming an on-market buy-back, retaining capital to support accelerated organic growth, or other means of returning surplus capital to shareholders.